BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10699107)

  • 21. Inhaled nitric oxide in premature infants with the respiratory distress syndrome.
    Schreiber MD; Gin-Mestan K; Marks JD; Huo D; Lee G; Srisuparp P
    N Engl J Med; 2003 Nov; 349(22):2099-107. PubMed ID: 14645637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
    Cummings JJ; D'Eugenio DB; Gross SJ
    N Engl J Med; 1989 Jun; 320(23):1505-10. PubMed ID: 2657423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M; Sardesai S; McEvoy C
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
    Yeh TF; Lin YJ; Lin HC; Huang CC; Hsieh WS; Lin CH; Tsai CH
    N Engl J Med; 2004 Mar; 350(13):1304-13. PubMed ID: 15044641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
    Vermont Oxford Network Steroid Study Group
    Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants.
    Kothadia JM; O'Shea TM; Roberts D; Auringer ST; Weaver RG; Dillard RG
    Pediatrics; 1999 Jul; 104(1 Pt 1):22-7. PubMed ID: 10390255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.
    Yeh TF; Lin HC; Chang CH; Wu TS; Su BH; Li TC; Pyati S; Tsai CH
    Pediatrics; 2008 May; 121(5):e1310-8. PubMed ID: 18426851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data.
    Kribs A; Härtel C; Kattner E; Vochem M; Küster H; Möller J; Müller D; Segerer H; Wieg C; Gebauer C; Nikischin W; Wense Av; Herting E; Roth B; Göpel W
    Klin Padiatr; 2010; 222(1):13-7. PubMed ID: 20084586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
    Gortner L; Wauer RR; Hammer H; Stock GJ; Heitmann F; Reiter HL; Kühl PG; Möller JC; Friedrich HJ; Reiss I; Hentschel R; Jorch G; Hieronimi G; Kuhls E
    Pediatrics; 1998 Nov; 102(5):1153-60. PubMed ID: 9794948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inositol supplementation in premature infants with respiratory distress syndrome.
    Hallman M; Bry K; Hoppu K; Lappi M; Pohjavuori M
    N Engl J Med; 1992 May; 326(19):1233-9. PubMed ID: 1560798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
    Bloomfield FH; Knight DB; Harding JE
    J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.
    Davis JM; Parad RB; Michele T; Allred E; Price A; Rosenfeld W;
    Pediatrics; 2003 Mar; 111(3):469-76. PubMed ID: 12612223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.